Evaluation of Inhaled Treatment in Sinusitis

Evaluation of Inhaled Corticosteroid Treatment in Sinusitis

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01907204

Enrollment

Registered

2013-07-24

Start date

2013-07-31

Completion date

2014-01-31

Last updated

2014-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinusitis

Brief summary

The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis

Interventions

DRUGmethylprednisolone

Oral 32mg/8d-16mg/4d-8mg/4d

DRUGBudesonide

Budesonide by metered dose inhaler

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Nasal/Sinus polyps

Exclusion criteria

* Previous sinus surgery * Age under 18y * Use of antibiotics

Design outcomes

Primary

Measure	Time frame
Sniffin' Sticks Test	Baseline and day 15

Secondary

Measure	Time frame
Specific quality of life questionnaire (Snot 20)	Baseline and day 15
Retro Olfaction Test	Baseline and day 15

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026